1. Home
  2. SCPH vs SSP Comparison

SCPH vs SSP Comparison

Compare SCPH & SSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCPH
  • SSP
  • Stock Information
  • Founded
  • SCPH 2013
  • SSP 1878
  • Country
  • SCPH United States
  • SSP United States
  • Employees
  • SCPH N/A
  • SSP N/A
  • Industry
  • SCPH Biotechnology: Pharmaceutical Preparations
  • SSP Broadcasting
  • Sector
  • SCPH Health Care
  • SSP Industrials
  • Exchange
  • SCPH Nasdaq
  • SSP Nasdaq
  • Market Cap
  • SCPH 173.6M
  • SSP 206.1M
  • IPO Year
  • SCPH 2017
  • SSP 1988
  • Fundamental
  • Price
  • SCPH $3.64
  • SSP $2.22
  • Analyst Decision
  • SCPH Strong Buy
  • SSP Strong Buy
  • Analyst Count
  • SCPH 3
  • SSP 1
  • Target Price
  • SCPH $14.00
  • SSP $8.00
  • AVG Volume (30 Days)
  • SCPH 423.8K
  • SSP 781.8K
  • Earning Date
  • SCPH 05-14-2025
  • SSP 05-08-2025
  • Dividend Yield
  • SCPH N/A
  • SSP N/A
  • EPS Growth
  • SCPH N/A
  • SSP N/A
  • EPS
  • SCPH N/A
  • SSP 0.93
  • Revenue
  • SCPH $41,982,000.00
  • SSP $2,472,701,000.00
  • Revenue This Year
  • SCPH $109.32
  • SSP N/A
  • Revenue Next Year
  • SCPH $76.95
  • SSP $9.21
  • P/E Ratio
  • SCPH N/A
  • SSP $2.39
  • Revenue Growth
  • SCPH 138.10
  • SSP 6.28
  • 52 Week Low
  • SCPH $1.94
  • SSP $1.36
  • 52 Week High
  • SCPH $5.65
  • SSP $4.06
  • Technical
  • Relative Strength Index (RSI)
  • SCPH 66.63
  • SSP 47.24
  • Support Level
  • SCPH $3.23
  • SSP $2.02
  • Resistance Level
  • SCPH $3.74
  • SSP $2.44
  • Average True Range (ATR)
  • SCPH 0.31
  • SSP 0.17
  • MACD
  • SCPH 0.08
  • SSP -0.00
  • Stochastic Oscillator
  • SCPH 93.81
  • SSP 32.26

About SCPH scPharmaceuticals Inc.

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.

About SSP E.W. Scripps Company (The)

The E W Scripps Co is a media enterprise with interests in local and national media brands. It owns and operates a collection of daily and community newspapers in medium-sized cities in the southern and western portions of the United States. The company's operating segment includes Local Media, Scripps Networks, and Other. It generates maximum revenue from the Local Media segment. The Local Media segment includes local broadcast stations and their related digital operations.

Share on Social Networks: